ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
ReRAD: A Phase II Canadian Pediatric Brain Tumour Consortium Study of Re-Irradiation as Treatment of Progressive or Recurrent Diffuse Intrinsic Pontine Glioma
Protocol ID
ReRAD
Condition/s
Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
Diagnosis Stage
Relapsed/ refractory
Location
NSW, QLD, VIC, WA, NZ
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
University of Calgary
Collaborators
Janeway Children's Health and Rehabilitation Centre
IWK Health Centre
St. Justine's Hospital
Montreal Children's Hospital of the MUHC
CHU de Quebec-Universite Laval
Children's Hospital of Eastern Ontario
The Hospital for Sick Children
McMaster Children's Hospital
London Health Sciences Centre
CancerCare Manitoba
Stollery Children's Hospital
Alberta Children's Hospital
British Columbia Children's Hospital
Trial Status
Open
Sites
The Children's Hospital at Westmead
Monash Children's Hospital
Perth Children's Hospital
Queensland Children's Hospital
Royal Children's Hospital
Starship Hospital
Study Type
Treatment
Phase
Phase 2
Age Eligibility
up to 17 years
International registry ID's
NCT03126266
Back to Registry
Study Title ReRAD: A Phase II Canadian Pediatric Brain Tumour Consortium Study of Re-Irradiation as Treatment of Progressive or Recurrent Diffuse Intrinsic Pontine Glioma
Protocol ID ReRAD
Disease (Sub Disease) Recurrent or Progressive Diffuse Intrinsic Pontine Glioma
Diagnosis Stage Relapsed/ refractory
Location NSW / QLD / VIC / WA / NZ
Sponsor Australian and New Zealand Children's Haematology Oncology Group/ University of Calgary
Collaborators Janeway Children's Health and Rehabilitation Centre/ IWK Health Centre/ St. Justine's Hospital/ Montreal Children's Hospital of the MUHC/ CHU de Quebec-Universite Laval/ Children's Hospital of Eastern Ontario/ The Hospital for Sick Children/ McMaster Children's Hospital/ London Health Sciences Centre/ CancerCare Manitoba/ Stollery Children's Hospital/ Alberta Children's Hospital/ British Columbia Children's Hospital
Links https://clinicaltrials.gov/ct2/show/NCT03126266
Trial Status Open
Trial Open Date 15/04/2017
Sites The Children's Hospital at Westmead / Monash Children's Hospital / Perth Children's Hospital / Queensland Children's Hospital / Royal Children's Hospital / Starship Hospital
Study Type Treatment
Phase Phase 2
Age Eligibility up to 17 years
International registry ID's NCT03126266

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168